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E-mail address: gilles.patey@univ-montp1.fr (G. PaVirB8 is a critical component of the Brucella suis type IV secretion system (T4SS). We previously
showed that the transmembrane (TM) domain plays an essential role in interactions of this protein
with itself and the other proteins of the T4SS. We report that a point mutation in this TM domain
stabilizes homodimers of VirB8 and heterodimers with VirB10. A similar variant of Agrobacterium
tumefaciens VirB8 showed the same phenotype. The B. suis VirB8 variant was unable to complement
a virB8 mutant and displayed a dominant negative phenotype when expressed in wild type B. suis.
We suggest that interaction of VirB8 with VirB10 could play a major role in the correct function of
the B. suis VirB T4SS.
Structured summary of protein interactions:
AtVirB8 physically interacts with AtVirB10 by two hybrid (View interaction)
TraJ physically interacts with TraJ by two hybrid (View Interaction 1, 2)
AtVirB8 physically interacts with AtVirB8 by two hybrid (View interaction)
VirB10 physically interacts with VirB10 by two hybrid (View interaction)
VirB8 physically interacts with VirB8 by two hybrid (View Interaction 1, 2)
VirB10 physically interacts with VirB8 by two hybrid (View interaction)
AtVirB10 physically interacts with AtVirB10 by two hybrid (View interaction)
VirB8 physically interacts with VirB10 by two hybrid (View interaction)
AtVirB10 physically interacts with AtVirB8 by two hybrid (View interaction)
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Bacterial type IV secretion systems (T4SS) are prokaryotic
nanomachines for the selective translocation of proteins and
DNA–protein complexes as well as serving to import DNA–protein
complexes. T4SS are essential virulence factors for many bacterial
pathogens [1,2], including Brucella [3,4] which are gram-negative
facultative intracellular pathogens responsible for the major
worldwide zoonosis brucellosis [5,6].
The Agrobacterium tumefaciens VirB/D4 T4SS is considered the
T4SS paradigm. It is composed of 12 different proteins VirB1–
VirB11 plus VirD4, which can be functionally subdivided in three
different groups [1]. VirB4, VirB11 and VirD4 are inner membrane
ATPases providing the energy for T4SS assembly and translocation
of effectors. VirB2 and VirB5 form an extracellular pilus [7]. Finally,chemical Societies. Published by E
e Médecine, 186 Chemin du
ance. Fax: +33 4 66 02 81 48.
tey).VirB3 and VirB6–VirB10 form a channel-like structure spanning
both the inner and outer membranes of the bacteria [8,9].
VirB8 plays a key role in the assembly of the A. tumefaciens T4SS
[10,11]. It is a bitopic membrane protein with a short amino termi-
nal cytoplasmic domain and a large carboxy terminal periplasmic
domain separated by a short transmembrane (TM) domain. Based
on the X-ray structures of the periplasmic domains of Brucella suis
and A. tumefaciens VirB8 [12,13], we used site-directed mutagene-
sis of speciﬁc residues to show that B. suis T4SS assembly and vir-
ulence requires dimerization of VirB8 and its interactions with
VirB4 and VirB10 [14].
We investigated the possibility of heterologous complementa-
tion of a B. suis VirB8 mutant using TraJ, the VirB8 homolog from
plasmid pSB102 which shares more than 50% identity at the amino
acid level with B. suis VirB8 (>60% identity for the periplasmic do-
main) [15,16]. We also tested chimeric proteins in which the major
part of the periplasmic domain of one protein (amino acids 77–236
of TraJ and amino acids 76–235 of VirB8) was replaced by the cor-
responding part of the other [15]. Interestingly, while the full length
protein did not complement, we did see partial complementationlsevier B.V. All rights reserved.
Table 2
Primers used in this study.
Oligonucleotide Sequence
B8GWF 50-ATTACCGTACTGCTCTGGATCGG-30
B8GWR 50-GATGCCGATCCAGAGCAGTACGG-30
B8GYF 50-ATCGCATATGCTTTCGGCAC-30
B8GYR 50-GCCGAAAGCATATGCGATTTT-30
TraJWGF 50-GTAGCGGTACTGTCTGGGCTCGC-30
TraJWGR 50-GATAGCGAGCCCAGACAGTACCG-30
TraJYGF 50-TACGTGGCCGGCGGAGCCGT-30
TraJYGR 50-TACGGCTCCGCCGGCCACGT-30
B10F 50-GCGGATCCATGACACAGGAAAACATTCC-30
B10R 50-GCGAATTCACTTCGGTTTGACATCAT-30
ATB8F 50-GCGGATCCATGACGGGGCCTGAATAT-30
ATB8R 50-GGGAATTCATGGTGCGCCCTGG-30
ATB8AWF 50-GTTGCGCAATGGTTCGCTATAG-30
ATB8AWR 50-AGCGAACCATTGCGCAACATTC-30
ATB10F 50-GGAGATCTATGAATAACGATAGTCAGCAA-30
ATB10R 50-CGGAATTCATTAAGAGCGGCG-30
2432 L. Andrieux et al. / FEBS Letters 585 (2011) 2431–2436with the chimera carrying the TraJ periplasmic domain. Bacterial
two hybrid (BACTH) analysis showed that VirB8, TraJ and the two
chimeric proteins all formed homodimers with a strength depend-
ing on the presence of TraJ TM. We suggested that inability of TraJ
and the TraJB8 chimera to complement were due to the formation
of this very strongly associated dimer. This led us to suggest that
VirB8 dimerization is a dynamic process and that the dimers must
be free to dissociate either during T4SS assembly or during sub-
strate translocation [17]. Here we analyze the role of two residues
in the TraJ TM domain and show that W60 is responsible for this
strong association.
2. Materials and methods
2.1. Bacterial strains and plasmids
Plasmids used in the study are described in Table 1. DNA
manipulation was in Escherichia coli XL1-Blue using standard tech-
niques while the adenylate cyclase deﬁcient E. coli BTH101 was
used for bacterial two-hybrid (BACTH) modiﬁed as described pre-
viously [17]. All Brucella strains were derived from B. suis 1330
(wild type) or B. suis BS008 (derived from 1330 with an in frame
deletion of virB8 gene) [15]. The sequences encoding A. tumefaciens
VirB8 and VirB10 were ampliﬁed from strain C58 using the primers
described in Table 2.
2.2. Site directed mutagenesis
Point mutations were introduced into virB8Bs, virB8At and traJ by
two rounds of PCR as described by Ho et al. [18] using primer pairs
described in Table 2.
2.3. Western blotting
Preparation of Brucella extracts, SDS–PAGE and Western blot-
ting was performed as described previously [15].Table 1
Plasmids used in this study.
Plasmid Properties
pIN38 pBBR1-MCS with a 1.1 kb DNA fragment carrying the B. suis virB promoter
pIN54 pBBR1-MCS with a 1.1 kb DNA fragment carrying the B. suis virB promoter
pIN215 pIN38 with a point mutation G59W in the TM domain of VirB8
pIN216 pIN54 with a point mutation W60G in the TM domain of TraJ
pIN73 pUT18C plasmid with the Pst1–EcoR1 fragment encompassing the multiple
pIN78 pIN73 with a BamH1–EcoR1 PCR fragment encoding VirB8
pIN79 pIN73 with a BamH1–EcoR1 PCR fragment encoding TraJ
pIN198 pIN78 with a point mutation G59W in the TM domain of VirB8
pIN199 pIN78 with a point mutation G49Y in the TM domain of VirB8
pIN200 pIN78 with both G59W and G49Y mutations in the TM domain of VirB8
pIN201 pIN79 with a point mutation W60G in the TM domain of TraJ
pIN202 pIN79 with a point mutation Y50G in the TM domain of TraJ
pIN203 pIN79 with both W60G and Y50G mutations in the TM domain of TraJ
pIN204 pIN73 with a BamH1–EcoR1 PCR fragment encoding wt A. tumefaciens VirB
pIN205 pIN204 with the point mutation A55W in the TM domain of AtVirB8
pIN227 pIN73 with a BamH1–EcoR1 PCR fragment encoding B. suis VirB10
pIN228 pIN73 with a BglII–EcoR1 PCR fragment encoding A. tumefaciens VirB10
pIN94 pKT25 with the unique Xba1 restriction site ﬁlled in with the Klenow DNA
pIN97 pIN94 with a BamH1–EcoR1 PCR fragment encoding VirB8
pIN98 pIN94 with a BamH1–EcoR1 PCR fragment encoding TraJ
pIN206 pIN97 with a point mutation G59W in the TM domain of VirB8
pIN207 pIN97 with a point mutation G49Y in the TM domain of VirB8
pIN208 pIN97 with both G59W and G49Y mutations in the TM domain of VirB8
pIN209 pIN98 with a point mutation W60G in the TM domain of TraJ
pIN210 pIN98 with a point mutation Y50G in the TM domain of TraJ
pIN211 pIN98 with both W60G and Y50G mutations in the TM domain of TraJ
pIN212 pIN94 with a BamH1–EcoR1 PCR fragment encoding wt A. tumefaciens VirB
pIN213 pIN212 with the point mutation A55W in the TM domain of AtVirB8
pIN225 pIN94 with a BamH1–EcoR1 PCR fragment encoding B. suis VirB10
pIN226 pIN94 with a BglII–EcoR1 PCR fragment encoding A. tumefaciens VirB102.4. Cell culture infection assays
Murine J774 macrophage like cells were maintained and in-
fected using a standard gentamicin protection assay as described
previously [15,17].
3. Results
3.1. Analysis of the VirB8 and TraJ TM domains
Comparison of the sequences of the TM domains of VirB8 (res-
idues 47–69) and TraJ (48–70) shows that in the TraJ TM domain
two aromatic residues (Tyr50 and Trp60) replace glycine residues
in VirB8 (Fig. 1). We hypothesized that Tyr50 and Trp60 might be
responsible for the differences observed between the stability of
homodimers of proteins containing the TM domain of TraJ and
those containing that of VirB8 [19]. We constructed variants whereReference
followed by the gene encoding VirB8 [15,17]
followed by the gene encoding TraJ [15,17]
This study
This study
cloning site replaced with the corresponding fragment from pKT25 [17]
[17]
[17]
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polymerase [17]
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Fig. 1. Schematic representation of the variants used in this study and comparison
of the amino acid sequences of VirB8Bs, TraJ and VirB8At transmembrane domains.
The conserved amino acids are in bold and the two glycine residues of VirB8Bs, the
corresponding tyrosine and tryptophan residues of TraJ and the alanine residue of
VirB8At which corresponds to glycine of VirB8Bs and tryptophan of TraJ are in larger
bold characters.
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changed to the corresponding amino acid of the other protein (Ta-
ble 1) and tested their abilities to form homodimers using BACTH.
3.2. Effects of aromatic residues in the TM domain on
homodimerisation
Changing Tyr50 to Gly in TraJ did not change its ability to form
heterodimers (b-galactosidase activity unchanged), whereas
changing Trp60 to Gly led to a 50% decrease in b-galactosidase
activity (Fig. 2). The G49Y change in VirB8 also had pronounced ef-
fects, leading to much weaker homodimers (30% decrease in activ-
ity compared to the WT). The G59W modiﬁcation led to a 30%
increase in interaction strength whether this change was intro-
duced in WT VirB8 or in the G49Y variant (Fig. 2).
3.3. Effects of the changes G59W (VirB8) and W60G (TraJ) on Brucella
virulence
We focused our in vivo study on the ability of VirB8 G59W and
TraJ W60G to restore virulence to the virB8mutant BS1008 [15]. As
previously observed, 48 h post-infection BS1008 complemented
with VirB8 was almost as virulent as 1330, whereas TraJ was un-
able to restore virulence of BS1008 (Fig. 3). As seen previously
[15], over-expression of VirB8 in 1330 led to a slight decrease in
virulence, whereas TraJ displayed a dominant negative effect inFig. 2. BACTH measurement of homodimeric interactions of VirB8 and TraJ, and variants.
represent the mean ± S.E.M. of ﬁve to six independent values. ⁄P < 0.05; ⁄⁄P < 0.01 (Studethis strain. Like WT TraJ, TraJ W60G was not able to complement
BS1008 and displayed a dominant negative effect in 1330. VirB8
G59W however showed a drastic change in behavior, as it was un-
able to restore the virulence to BS1008 and displayed a dominant
negative behavior in 1330.
3.4. VirB8 G59W is stable and does not affect bacterial growth rate
To ascertain that the lack of complementation of the BS1008
mutant by VirB8 G59W was not due to low levels of expression
or instability of this protein, we compared the expression of VirB8
G59W with that of WT VirB8. Bacterial extracts were prepared
from BS1008 strain transformed with pIN38 or pIN215 which al-
low the expression of these proteins under the control of the virB
promoter. As has been previously demonstrated, transcription of
B. suis virB operon is induced when the bacteria are cultured in
minimal medium at acidic pH [20], which mimics the conditions
in the phagosome and as a consequence the expression of VirB pro-
teins is greatly increased under these conditions [15]. As seen pre-
viously for WT VirB8 [15], in BS1008 strain complemented with
WT VirB8 or VirB8 G59W similar amounts of these proteins were
detected under all conditions tested (Fig. 4). Finally no effects were
seen on the growth rates of BS1008 expressing the two proteins in
rich medium (TS) as compared to 1330 and BS1008, with doubling
times of approximately 2 h (data not shown).
3.5. G59W inﬂuences interactions between VirB8 and VirB10
To look for other possible explanations for the lack of comple-
mentation by VirB8 G59W, we examined interaction with VirB10
which spans both the inner and outer membranes as part of the
double walled T4SS channel with VirB7 and VirB9 [8,21]. Beta-
galactosidase activity resulting from interactions between VirB10
and VirB8 G59W were higher than those resulting from interac-
tions between VirB10 and WT VirB8, suggesting that VirB8 G59W
interacts with VirB10 more strongly than WT VirB8 (Fig. 5).
3.6. Introduction of aromatic residues in the TM domain of A.
tumefaciens VirB8 inﬂuences homodimerisation and interaction with
VirB10
We constructed a similar variant of the A. tumefaciens VirB8
protein (VirB8At A55W). Using BACTH with cultures incubated atFor VirB8 the ﬁgure has been enlarged to make the differences more visible. Results
nt’s t-test).
Fig. 3. Infection of J774 macrophage cells with wild type B. suis strain 1330, BS1008 mutant strain and 1330 or BS1008 containing different plasmids allowing the expression
of wt VirB8 or TraJ or the variants VirB8 GW (VirB8 with the change Gly59? Trp) or TraJ WG (TraJ with the change Trp60? Gly). Only the results obtained 48 h after the
beginning of the infection are presented. ⁄P < 0.05 vs 1330; ⁄⁄P < 0.01 vs BS1008/pIN38 (Student’s t-test).
Fig. 4. Expression of WT VirB8 and G59W variant in different B. suis strains under
virB inducing (pH 4.5) and non-inducing (pH 7) conditions.
Fig. 5. Beta-galactosidase activities resulting from interactions between VirB10 and e
represented. Results represent the mean ± S.E.M. of eight or nine independent values
compared with values obtained for WT VirB8.
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with VirB10At were not stable, giving rise to an activity almost not
different from the negative control. In contrast the stability of
homodimers of VirB8At A55W as well as the heterodimers of Vir-
B8At A55W with VirB10At was at least 10–50 times the value ob-
tained for the negative control (Fig. 6). This underlines the effect
of the presence of the aromatic residue in this particular position
in the TM domain.ither VirB8 or VirB8 G59W. For practical reasons the ZIP column has not been
. ⁄P < 0.05 and ⁄⁄P < 0.01 (Student’s t-test) values obtained for the G59W mutant
Fig. 6. Beta-galactosidase activities resulting from interactions between A. tumefaciens VirB10 and either VirB8 or VirB8 A55W. For practical reasons the ZIP column has not
been represented. Overnight incubations were performed at 30 C instead of 37 C in the case of B. suis proteins. Results represent the mean ± S.E.M. of four to six independent
values. ⁄P < 0.05 and ⁄⁄P < 0.001 (Student’s t-test) values obtained for the A55W variant compared with values obtained for WT AtVirB8.
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This report strengthens our previous ﬁndings that the TM do-
main of VirB8 plays a role in the correct function of the B. suis
T4SS, by modulating the strength of interactions of VirB8 with it-
self and other T4SS proteins [17]. Here we show that a single amino
acid change in this domain has a profound negative effect on B. suis
virulence.
Comparison of the TM domains of VirB8 and TraJ showed that
two bulky, hydrophobic, aromatic amino acids (Tyr50 and Trp60)
in the TraJ TM domain replace two Gly residues located at the cor-
responding positions in the VirB8 TM domain. According to our
hypothesis concerning the role of this TM domain on the stability
of the homodimers of these proteins we investigated whether
these bulky amino acids present in TraJ TM could be responsible
for the stronger interactions [19]. Tyr50 was not responsible as var-
iant proteins VirB8 G49Y and TraJ Y50G showed no changes in
homo- or heterodimeric interactions compared to wild type except
for a small decrease in the stability of VirB8 homodimers (Fig. 2
and data not shown). We have no clear interpretation for this latter
result; however the presence in VirB8 of Phe51 close to Gly49 which
is changed to Tyr in VirB8 G49Ymight explain the decreased stabil-
ity of homodimers of this variant due to a steric hindrance between
these bulky aromatic amino acids. In contrast, VirB8 G59W and
TraJ W60G showed changes in homodimer stability in agreement
with our starting hypothesis (Fig. 2). When we tested the effects
of these proteins on Brucella virulence we found as expected that
VirB8 G59W was unable to restore virulence to the virB8 mutant
and had a dominant negative effect on virulence of the wild type
strain conﬁrming our observation that the formation of strongly
associated VirB8 dimers inhibited T4SS function [17]. Despite hav-
ing a reduced interaction, TraJ W60G was still unable to comple-
ment the virB8 possibly because the interactions are still too
strong, but equally there may be other key residues still missing.We attempted to explore other possible explanations for these
effects of the G59W change in VirB8. It seems unlikely that the lack
of complementation of BS1008 by VirB8 G59W results from an im-
paired expression of this protein in BS1008 or an intrinsic inability
of the strain BS1008 expressing VirB8 G59W to replicate. An alter-
native explanation rely on the interactions of VirB8 with other pro-
teins of the B. suis T4SS. We focused on the interactions of VirB8
with VirB10, as this latter protein is, like VirB8, inserted into the
bacterial inner membrane and its periplasmic domain interacts di-
rectly with that of VirB8 [14]. In addition recent cryo-EM studies
have demonstrated that VirB10 forms a large complex through
both inner and outer bacterial membranes with VirB7 and VirB9
[8,9]. Our present results suggest that VirB8 G59W interacts more
strongly with VirB10 than WT VirB8. Thus the G59W mutation af-
fects heterodimeric interactions between VirB8 and VirB10 as well
as homodimeric interactions of VirB8. TraJ also interacts more
strongly than VirB8 with VirB10 but these interactions are not af-
fected by the W60G change (data not shown). This lack of effect of
the W60G change on TraJ–Vir10 interactions, in parallel with the
results obtained in infection experiments suggest that these latter
in vivo effects might reﬂect more adequately the lack of changes in
interactions of TraJ with VirB10 than the changes in homodimeric
interactions of TraJ. At the present time we cannot exclude that the
G59W change also affects interactions of VirB8 with other compo-
nents of the T4SS. As suggested by the low b-galactosidase activi-
ties resulting from the interactions between VirB10 and VirB8
these interactions are likely weak, which might explain the ab-
sence of VirB8 in the large protein complex observed in EM studies
[8,9]. Although the exact function of the proteins encoded in
pSB102 tra operon is not yet known the close similarity of several
of themwith Brucella VirB proteins suggest that they would be part
of a T4SS. Because TraJ forms more stable dimers with B. suis
VirB10 as well as with its homolog TraL from pSB102 (data not
shown) than VirB8 itself, TraJ might be part of a complex with TraI,
2436 L. Andrieux et al. / FEBS Letters 585 (2011) 2431–2436TraK and TraL (homologous to Brucella VirB7, VirB9 and VirB10).
Such a complex might represent a valuable alternative to study
the role of a VirB8 homolog in the structure of the transmembrane
channel.
A single amino acid change in the TM domain of VirB8 changing
a small amino acid Gly into a large aromatic Trp residue is able to
stabilize homodimers of VirB8 and heterodimers between VirB8
and VirB10. These changes result in a variant VirB8 protein which
behaves in vivo like TraJ. Our data do not show which step in T4SS
function is affected; is it T4SS assembly or effector translocation?
In the absence of a suitable assay in Brucella an interesting alterna-
tive would be to use Agrobacterium as a surrogate model where the
biochemical tools exist to study T4SS assembly. In addition two
different assays have been developed to follow effector transloca-
tion. We show here that change of the Ala55 residue in the TM do-
main of VirB8At to Trp produces similar effects on BACTH as the
change of the corresponding Gly59 in VirB8Bs. It must be noted that,
in contrast to WT VirB8Bs, in our conditions WT VirB8At was almost
unable to form stable homodimers and heterodimers with Vir-
B10At. This could be related with the temperature (30 C) we have
used to perform this assay in the case of Agrobacterium, which
might be too elevated as already suggested by previous studies
[22]. Using the Transfer DNA ImmunoPrecipitation (TrIP) assay
[23] will allow us follow the different successive steps during the
transport of the Ti plasmid from the bacterial cell to the host cell,
while the Cre Recombinase Reporter Assay for Translocation
(CRAfT) assay [24] allows the detection of effector proteins trans-
ported from the bacterium once they are in the host cell. It would
be also interesting to test VirB8At A55W for its ability to comple-
ment an A. tumefaciens strain deleted in the virB8 gene as well as
any possible dominant negative effect on wild type virulence. A re-
cent report using a V97C variant in Agrobacterium VirB8, a protein
that forms strong dimers in the periplasm, suggested that pilus
assembly was affected rather than substrate translocation [25]. If
this variant protein appears unable to restore the virulence of this
strain, the use of the TrIP and CRAfT assays should allow the
assessment of the particular step in the process of transfer of pro-
teins or nucleoproteins from this bacterium to the host cell which
is impacted by this mutation.
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